« Consumer Product Safety Commission Product Safety Reporting Awareness | Main | Admissibility of Scientific Studies Developed for Use in Litigation »

April 8, 2006

A New York Times article reports that a top Food and Drug Administration official said the FDA intends to strengthen its monitoring method for heart devices such as defibrillators by appointing outside medical experts to assist in reviewing the safety of units that are already on the market.  The FDA has traditionally used advisory panels to determine whether to permit the sale of a new device, but not for post-sale reviews.  By Barry Meier.


April 8, 2006 | Permalink


TrackBack URL for this entry:

Listed below are links to weblogs that reference :


Post a comment